CLEVELAND BIOLABS INC (42) | Business Finance (25)

Browse by Subcategory

Recent Contracts

Forbearance and Second Amendment to Loan Documents, dated April 18, 2022 (Filed With SEC on May 27, 2022)
Form of Form of Pre-funded Warrant (Filed With SEC on March 25, 2022)
Form of Underwriting Agreement, dated March 22, 2022, by and between Statera Biopharma, Inc. and EF Hutton, a division of Benchmark Investments, LLC (Filed With SEC on March 25, 2022)
Form of Waiver (Filed With SEC on March 22, 2022)
Form of Securities Purchase Agreement, dated February 6, 2022, by and between Statera Biopharma, Inc. and the investor party thereto (Filed With SEC on February 7, 2022)
Amended and Restated Registration Rights Agreement, dated as of July 27, 2021, by and among GEM Global Yield LLC SCS, GEM Yield Bahamas Limited and Cytocom Inc (Filed With SEC on August 2, 2021)
Amended and Restated Share Purchase Agreement, dated as of July 27, 2021, by and among GEM Global Yield LLC SCS, GEM Yield Bahamas Limited and Cytocom Inc (Filed With SEC on August 2, 2021)
Award/Contract W81XWH-15-0570 modification dated September 29, 2020 issued by USA Med Research ACQ Activity (Filed With SEC on November 16, 2020)
Form of Five Year Common Stock Purchase Warrant (Filed With SEC on March 25, 2022)
Form of One Year Common Stock Purchase Warrant (Filed With SEC on March 25, 2022)
Form of Common Stock Purchase Warrant (Filed With SEC on February 7, 2022)
Warrant to Purchase Shares of Common Stock of Cytocom Inc., dated as of July 27, 2021, issued to Avenue Venture Opportunities Fund, L.P (Filed With SEC on August 2, 2021)
Warrant to Purchase Shares of Cytocom Inc., dated as of July 27, 2021, issued to GEM Yield Bahamas Limited (Filed With SEC on August 2, 2021)
Supplement to the Loan and Security Agreement dated as of April 26, 2021 between Cytocom, Inc. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on August 2, 2021)
Loan and Security Agreement, dated as of April 26, 2021, by and among Cytocom, Inc. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on August 2, 2021)
Form of Securities Purchase Agreement, dated as of February 19, 2021, between Cleveland BioLabs, Inc. and the purchasers named therein (Filed With SEC on February 23, 2021)
Form of Placement Agent Warrant (Filed With SEC on February 23, 2021)
Award/Contract W81XWH-15-0101 modification dated September 29, 2020 issued by USA Med Research ACQ Activity (Filed With SEC on November 16, 2020)
Award/Contract W81XWH-15-0570 modification dated July 31, 2020 issued by USA Med Research ACQ Activity (Filed With SEC on August 14, 2020)
Award/Contract W81XWH-15-0101 modification dated July 31, 2020 issued by USA Med Research ACQ Activity (Filed With SEC on July 31, 2020)
Form of Securities Purchase Agreement, dated as of June 1, 2020, between Cleveland BioLabs, Inc. and the purchasers named therein (Filed With SEC on June 3, 2020)
Form of Placement Agent Warrant (Filed With SEC on June 3, 2020)
Form of Warrant (Filed With SEC on June 3, 2020)
Award/Contract W81XWH-15-0101 modification dated March 18, 2020 issued by USA Med Research ACQ Activity (Filed With SEC on April 15, 2020)
Award/Contract W81XWH-15-C-0101 modification dated February 28, 2019 issued by USA Med Research ACQ Activity (Filed With SEC on May 15, 2019)